Reliance Other Income (Expense) decreased by 175.0% to -$3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 500.0%, from -$500.00K to -$3.00M. Over 2 years (FY 2023 to FY 2025), Other Income (Expense) shows a downward trend with a -45.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$600.00K | $600.00K | -$3.30M | -$9.30M | -$8.90M | $5.80M | $9.30M | $8.20M | $18.00M | $12.80M | $7.70M | -$2.00M | $1.70M | -$500.00K | $6.40M | $2.30M | $4.00M | -$3.00M |
| QoQ Change | — | +200.0% | -650.0% | -181.8% | +4.3% | +165.2% | +60.3% | -11.8% | +119.5% | -28.9% | -39.8% | -126.0% | +185.0% | -129.4% | >999% | -64.1% | +73.9% | -175.0% |
| YoY Change | — | — | — | <-999% | <-999% | +275.8% | +200.0% | +192.1% | — | +120.7% | -17.2% | -124.4% | -90.6% | -103.9% | -16.9% | +215.0% | +135.3% | -500.0% |